Prospective Prostate Cancer and Patient-reported Outcomes Registry

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2030

Conditions
Prostate CancerAdenocarcinoma of the ProstateLocally Advanced Prostate CarcinomaLocally Advanced Prostate Adenocarcinoma
Interventions
OTHER

standard of care

"No other procedures than those performed during the usual care for prostate cancer patients will be done. No study medication will be provided as part of participation.~Clinical outcomes will be reported via predefined electronic forms, integrated into the electronic health record (EHR). Patient-reported outcomes will be collected electronically.~All treatment decisions will be made at the discretion of the investigator or treating physician."

Trial Locations (4)

3000

RECRUITING

University Hospitals Leuven, Leuven

8000

RECRUITING

AZ Sint-Jan Brugge, Bruges

8500

RECRUITING

AZ Groeninge Kortrijk, Kortrijk

9200

RECRUITING

AZ Sint-Blasius, Dendermonde

All Listed Sponsors
collaborator

AZ Sint-Jan AV

OTHER

collaborator

General Hospital Groeninge

OTHER

collaborator

AZ Sint-Blasius Dendermonde

UNKNOWN

lead

Universitaire Ziekenhuizen KU Leuven

OTHER